
Takeda Pharmaceutical Company Limited TAK
$ 17.91
0.48%
Quarterly report 2022-Q1
added 06-29-2022
Takeda Pharmaceutical Company Limited ROA Ratio 2011-2026 | TAK
Annual ROA Ratio Takeda Pharmaceutical Company Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.91 | 0.35 | 0.79 | 4.55 | 2.64 | 2.1 | -3.39 | 2.33 | 3.32 | 3.47 | 8.9 |
All numbers in JPY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.9 | -3.39 | 2.54 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Aligos Therapeutics
ALGS
|
-27.33 | $ 8.67 | 0.35 % | $ 85.7 M | ||
|
Allakos
ALLK
|
-76.23 | - | - | $ 28.6 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.6 | -1.64 % | $ 8.66 B | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-44.67 | $ 3.27 | 4.98 % | $ 279 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1008.51 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-218.41 | - | - | $ 8.42 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B | ||
|
BioNTech SE
BNTX
|
65.02 | $ 99.34 | 2.73 % | $ 27.2 B | ||
|
bluebird bio
BLUE
|
-34.23 | - | - | $ 546 M | ||
|
Burford Capital Limited
BUR
|
5.51 | $ 4.72 | 5.23 % | $ 751 M | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
Cabaletta Bio
CABA
|
-101.68 | $ 3.23 | 0.94 % | $ 325 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.02 | $ 21.6 | 1.12 % | $ 1.01 B | ||
|
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Clearside Biomedical
CLSD
|
-95.49 | - | - | $ 25.3 M | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-1.42 | $ 1.54 | 4.76 % | $ 396 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.05 | 4.45 % | $ 5.02 M | ||
|
Aquestive Therapeutics
AQST
|
-52.23 | $ 4.21 | 0.36 % | $ 450 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 25.33 | 5.01 % | $ 3.22 B | ||
|
Chimerix
CMRX
|
-38.58 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-48.42 | - | - | $ 401 M | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
-44.38 | $ 33.59 | 3.07 % | $ 2.23 B | ||
|
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.49 | 1.1 % | $ 397 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
Cidara Therapeutics
CDTX
|
-79.06 | - | - | $ 1.41 B | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
CNS Pharmaceuticals
CNSP
|
-183.81 | $ 2.46 | -1.99 % | $ 1.09 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
CTI BioPharma Corp.
CTIC
|
-73.85 | - | - | $ 1.2 B | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M |